Enliven Therapeutics Inc. (ELVN)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
22.67
2.21 (10.80%)
At close: Jan 15, 2025, 1:32 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Cash & Equivalents | 100.14M | 75.54M | 110.02M | 130.37M | 4.94M | 7.38M | 9.67M |
Short-Term Investments | 153.01M | n/a | 41.97M | 40.52M | 23.97M | n/a | n/a |
Long-Term Investments | n/a | 54.00K | 175.00K | 88.00K | 88.00K | n/a | n/a |
Other Long-Term Assets | 4.65M | 3.98M | 1.53M | -88.00K | 2.14M | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 13.00M | 2.22M | 646.00K | 222.00K | 1.72M | 323.00K | 552.00K |
Total Current Assets | 266.15M | 77.75M | 110.67M | 130.59M | 30.62M | 7.71M | 10.22M |
Property-Plant & Equipment | 1.06M | 1.52M | 954.00K | 416.00K | 442.00K | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 5.72M | 5.54M | 2.66M | 416.00K | 2.67M | n/a | n/a |
Total Assets | 271.87M | 83.30M | 113.33M | 131.00M | 33.30M | 7.71M | 10.22M |
Account Payables | 532.00K | 3.44M | 2.52M | 808.00K | 1.66M | 908.00K | 431.00K |
Deferred Revenue | n/a | 5.51M | 2.70M | 429.00K | n/a | n/a | n/a |
Short-Term Debt | 335.00K | 323.00K | 159.00K | 105.00K | n/a | n/a | n/a |
Other Current Liabilities | 25.03M | 5.95M | 3.07M | 565.00K | 2.54M | 924.00K | 395.00K |
Total Current Liabilities | 25.89M | 9.71M | 5.75M | 1.48M | 4.20M | 1.83M | 826.00K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | 660.00K |
Other Long-Term Liabilities | 67.00K | 150.41M | 150.46M | 149.83M | 184.00K | 32.19M | n/a |
Total Long-Term Liabilities | 67.00K | 150.41M | 150.46M | 149.83M | 184.00K | 32.19M | 660.00K |
Total Liabilities | 25.96M | 160.12M | 156.22M | 151.31M | 4.38M | 1.83M | 1.49M |
Total Debt | 335.00K | 323.00K | 159.00K | 105.00K | n/a | n/a | 660.00K |
Common Stock | 41.00K | 1K | 1K | 1K | 4.00K | 4.00K | 4.00K |
Retained Earnings | -154.45M | -82.86M | -45.20M | -20.46M | -54.75M | -31.29M | -19.95M |
Comprehensive Income | 141.00K | -149.75K | -16.00K | 4.00K | 32.00K | n/a | n/a |
Shareholders Equity | 245.91M | -76.83M | -42.89M | -20.30M | -48.85M | -26.32M | -15.53M |
Total Investments | 153.01M | 54.00K | 42.14M | 40.61M | 24.06M | n/a | n/a |